PT  - JOURNAL ARTICLE
AU  - Meng, Sijun
AU  - Zheng, Yueping
AU  - Su, Ruizhang
AU  - Wang, Wangyue
AU  - Zhang, Yu
AU  - Xiao, Hang
AU  - Han, Zhaofang
AU  - Zhang, Wen
AU  - Qin, Wenjuan
AU  - Yang, Chen
AU  - Yan, Lichong
AU  - Xu, Haineng
AU  - Bu, Yemei
AU  - Zhong, Yuhuan
AU  - Zhang, Yi
AU  - He, Yulong
AU  - Qiu, Hesong
AU  - Xu, Wen
AU  - Chen, Hong
AU  - Wu, Siqi
AU  - Jiang, Zhenghua
AU  - Zhang, Yongxiu
AU  - Dong, Chao
AU  - Hu, Yongchao
AU  - Xie, Lizhong
AU  - Li, Xugong
AU  - Jiang, Jianping
AU  - Zhu, Huafen
AU  - Li, Wenxia
AU  - Wen, Zhang
AU  - Zheng, Xiaofang
AU  - Sun, Yuanlong
AU  - Zhou, Xiaolu
AU  - Ding, Limin
AU  - Zhang, Changhua
AU  - Pan, Wensheng
AU  - Wu, Shuisheng
AU  - Hu, Yiqun
TI  - Artificial intelligence assisted standard white light endoscopy accurately characters early colorectal cancer: a multicenter diagnostic study
AID  - 10.1101/2020.02.21.20025650
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.21.20025650
4099  - http://medrxiv.org/content/early/2020/02/23/2020.02.21.20025650.short
4100  - http://medrxiv.org/content/early/2020/02/23/2020.02.21.20025650.full
AB  - Colorectal cancer (CRC) is the third in incidence and mortality1 of cancer. Screening with colonoscopy has been shown to reduce mortality by 40-60%2. Challenge for screening indistinguishable precancerous and noninvasive lesion using conventional colonoscopy was still existing3. We propose to establish a propagable artificial intelligence assisted high malignant potential early CRC characterization system (ECRC-CAD). 4,390 endoscopic images of early CRC were used to establish the model. The diagnostic accuracy of high malignant potential early CRC was 0.963 (95% CI, 0.941-0.978) in the internal validation set and 0.835 (95% CI, 0.805-0.862) in external datasets. It achieved better performance than the expert endoscopists. Spreading of ECRC-CAD to regions with different medical levels can assist in CRC screening and prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMajor Science and Technology Project of Zhejiang Provincial 46 (2020C03030), Natural 47 Science Foundation of Fujian Province (2019-CXB-31), Science and technology program of Guangdong 48 Province (2016A020213002), and National Natural Science Foundation of China (81773956)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data would be available upon requests to corresponding authors.